Accréditation du criblage toxicologique : recommandations du groupe SFBC-SFTA (notice n° 83574)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 03288cam a2200421 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250112000319.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Guitton, Jérôme |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Accréditation du criblage toxicologique : recommandations du groupe SFBC-SFTA |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2019.<br/> |
500 ## - GENERAL NOTE | |
General note | 30 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | RésuméLe criblage toxicologique est une approche spécifique de la toxicologie analytique qui fait appel à des outils analytiques tels que la CG-SM, la CL-UV (barrette de diodes) ou la CL-SM. Le criblage toxicologique permet la détection et l’identification simultanées d’un grand nombre de composés. Les résultats peuvent être basés sur l’emploi d’une ou de plusieurs techniques. Dans le cadre du processus d’accréditation des examens de biologie médicale selon la norme NF EN ISO 15189, le groupe issu des sociétés savantes SFTA et SFBC recommande une démarche pour accréditer le criblage toxicologique. En effet, la complexité de l’accréditation de cette analyse provient en particulier du nombre élevé de composés susceptibles d’être détectés. Les paramètres de validation sont discutés dans le cadre spécifique du criblage toxicologique en considérant deux approches distinctes : l’identification des composés, ou l’identification et l’estimation d’une zone de concentration. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Toxicological screening is a specific approach to analytical toxicology that uses analytical tools such as GC-MS, LC-UV (diode array) or LC-MS. Toxicological screening allows the detection and simultaneous identification of a large number of compounds. The results may be based on the use of one or more techniques. As part of the accreditation process for medical biology examinations according to standard NF EN ISO 15189, the group from SFTA and SFBC recommends an approach to accredit toxicological screening. Indeed, the complexity of the accreditation of this analysis comes in particular from the high number of compounds that can be detected. Validation parameters are discussed in the specific context of toxicological screening by considering two distinct approaches: the simple identification of compounds, or the identification and estimation of a range of concentration related to clinical outcomes. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | criblage toxicologique |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | accréditation |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | ISO 15189 |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | norme |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | ISO standard |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | ISO 15189 |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | toxicological screening |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | accreditation |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gaulier, Jean-Michel |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Citterio-Quentin, Antony |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abe, Emuri |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Allibé, Nathalie |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bartoli, Mireille |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cohen, Sabine |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Monteil-Ganiere, Catherine |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Garcia-Hejl, Carine |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grosjean, Jérôme |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Richard, Damien |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roman, Emilie |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Saint-Marcoux, Franck |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wendremaire, Maeva |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Annales de Biologie Clinique | 77 | 2 | 2019-03-01 | p. 219-224 | 0003-3898 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-annales-de-biologie-clinique-2019-2-page-219?lang=fr">https://shs.cairn.info/revue-annales-de-biologie-clinique-2019-2-page-219?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux